國立虎尾科技大學 |

登入

回首頁

Resistance to Tyrosine Kinase Inhibitors

SpringerLink (Online service)

Resistance to Tyrosine Kinase Inhibitors

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Resistance to Tyrosine Kinase Inhibitors/ edited by Daniele Focosi.
其他作者:	Focosi, Daniele.
面頁冊數:	XIII, 188 p. 8 illus., 6 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cancer research. -
電子資源:	https://doi.org/10.1007/978-3-319-46091-8
ISBN:	9783319460918

Resistance to Tyrosine Kinase Inhibitors
Resistance to Tyrosine Kinase Inhibitors[electronic resource] /edited by Daniele Focosi. - 1st ed. 2016. - XIII, 188 p. 8 illus., 6 illus. in color.online resource. - Resistance to Targeted Anti-Cancer Therapeutics,2196-5501. - Resistance to Targeted Anti-Cancer Therapeutics,4.

Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells -- Resistance to Tyrosine Kinase Inhibitors in different types of solid cancer -- The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview -- Resistance to FLT3 Inhibitors -- Resistance to ALK inhibitors -- Resistance to Angiokinase Inhibitors -- Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors.

The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.

ISBN: 9783319460918

Standard No.: 10.1007/978-3-319-46091-8doiSubjects--Topical Terms:

1253664
Cancer research.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Resistance to Tyrosine Kinase Inhibitors
LDR:02318nam a22004095i 4500 001 976868
003 DE-He213
005 20200705130650.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319460918 $9 978-3-319-46091-8
024 7 $a 10.1007/978-3-319-46091-8 $2 doi
035 $a 978-3-319-46091-8
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Resistance to Tyrosine Kinase Inhibitors $h [electronic resource] / $c edited by Daniele Focosi.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a XIII, 188 p. 8 illus., 6 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Resistance to Targeted Anti-Cancer Therapeutics, $x 2196-5501
505 0 $a Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells -- Resistance to Tyrosine Kinase Inhibitors in different types of solid cancer -- The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview -- Resistance to FLT3 Inhibitors -- Resistance to ALK inhibitors -- Resistance to Angiokinase Inhibitors -- Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors.
520 $a The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.
650 0 $a Cancer research. $3 1253664
650 1 4 $a Cancer Research. $3 668358
700 1 $a Focosi, Daniele. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1115280
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319460901
776 0 8 $i Printed edition: $z 9783319460925
776 0 8 $i Printed edition: $z 9783319834382
830 0 $a Resistance to Targeted Anti-Cancer Therapeutics, $x 2196-5501 ; $v 4 $3 1254768
856 4 0 $u https://doi.org/10.1007/978-3-319-46091-8
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得

Export

取書館別